Seung Won Oh1, Hyo Soon Lim1, Sung Min Moon1, Jin Woong Kim1, Sang Soo Shin1, Suk Hee Heo1, Ji Shin Lee2, Min Ho Park3. 1. 1 Department of Radiology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea. 2. 2 Department of Pathology, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea. 3. 3 Department of Surgery, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Jeollanam-do, Korea.
Abstract
OBJECTIVES: To describe the MR imaging characteristics of breast cancer diagnosed during lactation and evaluate the usefulness of MR imaging. METHODS: The MR images of nine patients (age range, 29-37 years) with pathologically confirmed breast carcinoma during lactation were evaluated retrospectively. Background parenchymal enhancement of the lactating mammary tissue was determined. The images were reviewed for evaluation of lesion detection, enhancement type (mass/non-mass), shape, margin, contrast enhancement and time-intensity curve pattern in the dynamic study. The breast MR images after neoadjuvant chemotherapy were also reviewed. RESULTS: Although the breasts showed marked (n = 7) or moderate (n = 2) background parenchymal enhancement, MR imaging depicted breast cancer in all patients. All nine tumours were visible as masses. The most common shape and margin of the masses were an irregular mass (n = 5) with an irregular margin (n = 9). Contrast enhancement was heterogeneous or rim enhancement. The predominant kinetic pattern was rapid increase (n = 9) in the initial phase and washout (n = 5) in the delayed phase. Additional sites of cancer other than the index lesion were detected with MR imaging in three patients (33.3%). MR imaging demonstrated partial response in five of six patients who were evaluated for response to chemotherapy. CONCLUSION: All breast cancers in lactating females in this study were observed on breast MR imaging despite the moderate-to-marked background parenchymal enhancement of lactating mammary tissue. Advances in knowledge: MR imaging can be used in the evaluation of disease extent and assessment of therapeutic response after neoadjuvant chemotherapy of breast cancer diagnosed during lactation.
OBJECTIVES: To describe the MR imaging characteristics of breast cancer diagnosed during lactation and evaluate the usefulness of MR imaging. METHODS: The MR images of nine patients (age range, 29-37 years) with pathologically confirmed breast carcinoma during lactation were evaluated retrospectively. Background parenchymal enhancement of the lactating mammary tissue was determined. The images were reviewed for evaluation of lesion detection, enhancement type (mass/non-mass), shape, margin, contrast enhancement and time-intensity curve pattern in the dynamic study. The breast MR images after neoadjuvant chemotherapy were also reviewed. RESULTS: Although the breasts showed marked (n = 7) or moderate (n = 2) background parenchymal enhancement, MR imaging depicted breast cancer in all patients. All nine tumours were visible as masses. The most common shape and margin of the masses were an irregular mass (n = 5) with an irregular margin (n = 9). Contrast enhancement was heterogeneous or rim enhancement. The predominant kinetic pattern was rapid increase (n = 9) in the initial phase and washout (n = 5) in the delayed phase. Additional sites of cancer other than the index lesion were detected with MR imaging in three patients (33.3%). MR imaging demonstrated partial response in five of six patients who were evaluated for response to chemotherapy. CONCLUSION: All breast cancers in lactating females in this study were observed on breast MR imaging despite the moderate-to-marked background parenchymal enhancement of lactating mammary tissue. Advances in knowledge: MR imaging can be used in the evaluation of disease extent and assessment of therapeutic response after neoadjuvant chemotherapy of breast cancer diagnosed during lactation.
Authors: Anjali C Talele; Priscilla J Slanetz; Whitney B Edmister; Eren D Yeh; Daniel B Kopans Journal: Breast J Date: 2003 May-Jun Impact factor: 2.431
Authors: Leandro A Espinosa; Bruce L Daniel; Logi Vidarsson; Marowan Zakhour; Debra M Ikeda; Robert J Herfkens Journal: Radiology Date: 2005-11 Impact factor: 11.105
Authors: E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij Journal: Eur J Cancer Date: 2009-01 Impact factor: 9.162
Authors: Bo Young Ahn; Hak Hee Kim; Woo Kyung Moon; Etta D Pisano; Hyeon Sook Kim; Eun Suk Cha; Jeung Sook Kim; Ki Keun Oh; Seog Hee Park Journal: J Ultrasound Med Date: 2003-05 Impact factor: 2.153
Authors: Beth M Beadle; Wendy A Woodward; Lavinia P Middleton; Welela Tereffe; Eric A Strom; Jennifer K Litton; Funda Meric-Bernstam; Richard L Theriault; Thomas A Buchholz; George H Perkins Journal: Cancer Date: 2009-03-15 Impact factor: 6.860